• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Device Problem Activation, Positioning or Separation Problem (2906)
Patient Problem Insufficient Information (4580)
Event Date 11/27/2020
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following article was reviewed by gore: "renal stent complications and impact on renal function after standard fenestrated endovascular aneurysm repair." authors: celine deslarzes-dubuis, kenneth tran, benjamin d.Colvard, jason t.Lee, annals of vascular surgery, volume 72, 2021, pages 106-113.A 60 total of gore® viabahn® vbx balloon expandable endoprosthesis (vbx) and 133 icast devices were utilized as bridging stents.17 total renal stent-related complications were reported including stent occlusions (n=4), stenosis (n=9), dislocation (n=3), and endoleak (n=1).All stent complications underwent reintervention with a technical success of 94.2%.Patients with occlusion were treated the day of diagnosis with a mean time from diagnosis to reintervention of 21.5 days.The study concludes with stating that: "fevar is a durable option for the treatment of juxtarenal aortic aneurysms and is associated with excellent secondary patency.Renal stent complications have no significant impact on renal function, but smaller native renal arteries are at higher risk of stent-graft complications." this case is covering the following allegations (none of which have specifically identified a vbx device as the medical device associated with the allegation): occlusion and stenosis with reported reintervention, device migration with reported reintervention, and an endoleak with a reported reintervention.This report is covering the allegation of an endoleak with reported reintervention.Further information has been requested but has not been made available at this time.
 
Manufacturer Narrative
The following fields were updated with additional information: patient information fields a2 and a3 were updated to reflect the mean patient age of 74 years and predominantly male study cohort (95%).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key11721092
MDR Text Key262287551
Report Number2017233-2021-01898
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Type of Report Initial,Followup,Followup
Report Date 10/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/23/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received03/26/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age74 YR
-
-